Taro Gets Tentative Approval From FDA For Terbinafine ...
Stocks rated 9 and 10 have outperformed the average stock by approximately 14 to 1 since 1995 and ideally are the stocks to focus on each day. Stocks rated 1 and 2 on average have lost money and you want to know these stocks in order to avoid them.
(RTTNews) - Taro Pharmaceutical Industries Ltd. (TARO Powerrating) reported that its U.S. affiliate has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Terbinafine Hydrochloride Cream 1%.
The FDA has determined that Taro's terbinafine cream is safe and effective for use when compared with the reference listed drug product, Lamisil Cream of Novartis Consumer Health Inc. (NVS Powerrating)
According to industry sources, Lamisil Cream has annual U.S. sales in excess of $45 million.
Copyright(c) 2006 RealTimeTraders.com, Inc. All Rights Reserved
About TradingMarkets What Customers Are Saying
All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.
This is cache, read story here